[go: up one dir, main page]

BR9809171A - Processo de tratamento de uma matéria-prima láctica, contendo gmp - Google Patents

Processo de tratamento de uma matéria-prima láctica, contendo gmp

Info

Publication number
BR9809171A
BR9809171A BR9809171-9A BR9809171A BR9809171A BR 9809171 A BR9809171 A BR 9809171A BR 9809171 A BR9809171 A BR 9809171A BR 9809171 A BR9809171 A BR 9809171A
Authority
BR
Brazil
Prior art keywords
raw material
resin
material containing
treatment process
lactic raw
Prior art date
Application number
BR9809171-9A
Other languages
English (en)
Other versions
BR9809171B1 (pt
Inventor
Peter Erdmann
Fred Neumann
Original Assignee
Soc D Produites Nestle S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Produites Nestle S A filed Critical Soc D Produites Nestle S A
Publication of BR9809171A publication Critical patent/BR9809171A/pt
Publication of BR9809171B1 publication Critical patent/BR9809171B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A23C9/1465—Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: <B>"PROCESSO DE TRATAMENTO DE UMA MATéRIA-PRIMA LáCTICA, CONTENDO GMP"<D>. Um processo industrial simples de troca de íons consiste em tratar uma matéria-prima láctica líquida que contém o glicomacropeptídeo na presença de uma resina aniónica fraca, de modo a se obter um produto protéico melhorado, utilizável na alimentação, e esse glicomacropeptídeo, que é adsorvido seletivamente sobre a resina, depois é eluído dessa resina. Antes do tratamento com a resina, a matéria-prima líquida é descationizada, de modo que o pH tenha um valor de 1 a 4,5.
BRPI9809171-9A 1997-05-27 1998-05-22 processo de tratamento de uma matéria-prima láctica, contendo glicomacropeptìdeo ou caseinoglicomacropeptìdeo (''gmp''). BR9809171B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201607.5 1997-05-27
EP97201607A EP0880902A1 (fr) 1997-05-27 1997-05-27 Procédé de traitement d'une matiére première lactosérique
PCT/EP1998/003176 WO1998053702A1 (fr) 1997-05-27 1998-05-22 Procede de traitement d'une matiere premiere lactique contenant du gmp

Publications (2)

Publication Number Publication Date
BR9809171A true BR9809171A (pt) 2000-08-01
BR9809171B1 BR9809171B1 (pt) 2011-01-11

Family

ID=8228378

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9809171-9A BR9809171B1 (pt) 1997-05-27 1998-05-22 processo de tratamento de uma matéria-prima láctica, contendo glicomacropeptìdeo ou caseinoglicomacropeptìdeo (''gmp'').

Country Status (9)

Country Link
US (1) US6787158B1 (pt)
EP (2) EP0880902A1 (pt)
JP (1) JP4286325B2 (pt)
AU (1) AU746520B2 (pt)
BR (1) BR9809171B1 (pt)
CA (1) CA2288184C (pt)
DE (1) DE69836909T2 (pt)
NZ (1) NZ500848A (pt)
WO (1) WO1998053702A1 (pt)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1048226E (pt) * 1999-04-29 2005-11-30 Nestle Sa Formula para lectentes que contem uma proteina de soro de leite doce
GB9923048D0 (en) 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
BR0010125A (pt) * 1999-04-29 2002-01-15 Nestle Sa Composição para uma fórmula para lactente tendo um baixo teor de treonina
CA2423934A1 (en) * 2000-10-10 2002-04-18 Bopa Ireland Limited A dairy product
AU2002345773A1 (en) * 2001-06-08 2002-12-23 Societe Des Produits Nestle S.A. Sugar-based composition containing caseinoglycomacropeptide
EP1638414B1 (en) * 2003-06-23 2009-06-17 Nestec S.A. Infant or follow-on formula
ATE491348T1 (de) * 2003-06-23 2011-01-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
EP2108269A1 (en) 2005-04-13 2009-10-14 Nestec S.A. Infant formula with low dose probiotics and low dose proteins
EP1870649A1 (en) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
FI120953B (fi) * 2007-06-26 2010-05-31 Valio Oy Menetelmä hyvin säilyvän vähälaktoosisen tai laktoosittoman maitotuotteen valmistamiseksi
EP2044851A1 (en) 2007-09-26 2009-04-08 Nestec S.A. Prevention of allergy at weaning
US20110048219A1 (en) * 2007-11-13 2011-03-03 Pyles Robert A Blast-resistant barrier
MX348901B (es) 2007-11-26 2017-07-03 Nestec Sa Sistema nutricional adaptado a la edad para infantes.
EP2096115A1 (en) 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
EP2116140A1 (en) * 2008-05-08 2009-11-11 Nestec S.A. Sialic acid to support the immune system in the elderly
MX2011003276A (es) * 2008-10-20 2011-04-28 Nestec Sa Composicion nutricional con propiedades anti-regurgitacion.
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
CA2749254A1 (en) 2009-01-19 2010-07-22 Catherine Mace Nutritional composition for infants
PL2413718T3 (pl) 2009-04-01 2017-08-31 Nestec S.A. Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu
KR101739326B1 (ko) 2009-04-02 2017-05-24 노보자임스 에이/에스 젖-기반 단백질 가수분해물의 제조 방법
MX2011010454A (es) 2009-04-03 2012-01-25 Nestec Sa Mejoramiento en la promocion de la sana recuperacion del crecimiento.
EP2251030A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
EP2251029A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and gut neuronal health in adults and/or elderly
EP2251031A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
EP2251032A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and protection in adults
JP2013510799A (ja) * 2009-11-11 2013-03-28 オーラル ヘルス オーストラリア ピーティーワイ リミテッド 抗バイオフィルム糖ペプチド
AU2010329990B2 (en) 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
WO2012004585A1 (en) * 2010-07-09 2012-01-12 Abdulla Badawy Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof
UA112972C2 (uk) 2010-09-08 2016-11-25 Інтерконтінентал Грейт Брендс ЛЛС Рідкий молочний концентрат з високим вмістом сухих речовин
EP2436389A1 (en) 2010-10-01 2012-04-04 Nestec S.A. Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
CA2836241A1 (en) 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
EA029154B1 (ru) 2012-02-06 2018-02-28 Арла Фудс Амба Низкобелковое замороженное кондитерское изделие
US20160193302A1 (en) 2013-09-02 2016-07-07 Nestec S.A. Lactoferrin and memory and learning speed in children
EP3073844B1 (en) 2013-11-29 2020-01-22 Société des Produits Nestlé S.A. Age-tailored nutritional compositions with a varying protein content
RU2692488C1 (ru) * 2013-12-13 2019-06-25 Нестек С.А. Использование модифицированной сладкой молочной сыворотки и детской смеси, содержащей модифицированную сладкую молочную сыворотку, для стимулирования постнатального развития центральной нервной системы и соответствующих когнитивных функций ребенка грудного возраста
MY186968A (en) 2013-12-16 2021-08-26 Nestle Sa Newly identified peptides for use in the induction of oral tolerance in young mammals
BR112016012869A2 (pt) 2013-12-19 2017-08-08 Nestec Sa Composição nutricional para reduzir o estresse metabólico em bebês
FI3255999T3 (fi) * 2015-02-09 2023-11-01 Nestle Sa Menetelmä cgmp:tä sisältävän makean heramateriaalin käsittelemiseksi ja siihen liittyvä menetelmä kohdennetun tryptofaani/treoniinisuhteen omaavan proteiinimateriaalin tuottamiseksi
RU2714051C2 (ru) * 2015-02-09 2020-02-11 Сосьете Де Продюи Нестле С.А. Способ обработки сладкой молочной сыворотки с получением белкового материала, пригодного для приготовления гипоаллергенных детских смесей
EP3277103B1 (en) 2015-03-30 2020-11-11 Société des Produits Nestlé S.A. Milk-based protein hydrolysates and compositions made thereof
AU2016274718B2 (en) 2015-06-12 2021-01-21 Société des Produits Nestlé S.A. Combination of tolerogenic peptides and TGF-β for use in the induction and maintenance of oral tolerance in young mammals
EP4205560A1 (en) 2015-12-14 2023-07-05 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas to promote myelination in the brain
AU2016374161A1 (en) 2015-12-14 2018-04-19 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
MX2018006294A (es) 2015-12-14 2018-11-09 Nestec Sa Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.
CN118902107A (zh) 2015-12-14 2024-11-08 雀巢产品有限公司 促进大脑髓鞘形成的营养组合物和婴儿配方食品
BR112018011835A2 (pt) 2015-12-14 2018-11-27 Nestec Sa composições nutricionais e fórmulas para bebês para promover mielinização no cérebro
SG11201803023UA (en) 2016-03-30 2018-05-30 Nestec Sa Compositions comprising minerals and their use
WO2017167898A2 (en) 2016-03-30 2017-10-05 Nestec S.A. Compositions and their use
SG11201803027PA (en) 2016-03-30 2018-05-30 Nestec Sa Compositions comprising phospholipid and their use
CN108367009A (zh) 2016-03-30 2018-08-03 雀巢产品技术援助有限公司 包含维生素的组合物及其用途
CN108697671A (zh) 2016-03-30 2018-10-23 雀巢产品技术援助有限公司 包含胆碱的组合物及其用途
WO2017167415A1 (en) 2016-03-30 2017-10-05 Nestec S.A. Compositions comprising fatty acids and their use
MX2019009299A (es) 2017-02-20 2019-09-13 Nestle Sa Composiciones nutricionales con proteinas parcialmente hidrolizadas para el uso en la induccion de respuesta(s) a la glucosa y/o insulina similar(es) a las observadas con leche humana.
EP3706586A1 (en) 2017-11-09 2020-09-16 Société des Produits Nestlé S.A. An array of age-tailored nutritional formula for infants and young children for use in the prevention of sub-optimal body composition
KR20200108829A (ko) 2018-01-16 2020-09-21 프리슬랜드캄피나 네덜란드 비.브이. 저알레르기성 영아용 조제식 및 이의 제조 방법
BR112021009955A2 (pt) 2018-12-19 2021-08-17 Société des Produits Nestlé S.A. Usos de um hidrolisado de proteína parcial do soro de leite, e composição para prevenirou reduzir a perda transepidérmica de água e melhorar a função de barreira da pele
US20240138461A1 (en) 2019-10-17 2024-05-02 Societe Des Produits Nestle S.A. Infant formula
CN114554872B (zh) 2019-10-17 2024-04-16 雀巢产品有限公司 深度水解的婴儿配方食品
CA3163781A1 (en) 2019-12-30 2021-07-08 Societe Des Produits Nestle S.A. Infant formula
EP4228436A1 (en) 2020-10-16 2023-08-23 Société des Produits Nestlé S.A. Nutritional composition comprising human milk oligosaccharides
AU2021376858A1 (en) 2020-11-10 2023-04-13 Société des Produits Nestlé S.A. Nutritional composition
EP4326076A1 (en) 2021-04-19 2024-02-28 Société des Produits Nestlé S.A. Use of milk protein fractions as a source of osteopontin
CN121152568A (zh) 2023-04-28 2025-12-16 雀巢产品有限公司 营养组合物
AU2024266362A1 (en) 2023-04-28 2025-10-16 Société des Produits Nestlé S.A. Nutritional composition
AU2024288910A1 (en) 2023-07-06 2026-01-08 Societe Des Produits Nestle S.A. Combination for dietary management of gut health

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1442298A (en) * 1972-09-01 1976-07-14 Ici Ltd Replenishment of fluidised beds
GB2188526B (en) * 1986-02-19 1990-10-10 Agricultural & Food Res A proteinaceous material obtainable from milk or casein-containing milk products ,process for its production and its use in food and drink
JP2622686B2 (ja) * 1987-05-15 1997-06-18 雪印乳業株式会社 ｋ−カゼイングリコマクロペプチドの製造法
FR2646775A1 (fr) 1989-05-11 1990-11-16 Centre Nat Rech Scient Utilisation du caseinoglycopeptide k, notamment de lait de vache, pour la fabrication d'une composition, notamment d'un medicament, pour la prevention et le traitement des thromboses
JP2961625B2 (ja) * 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法
JP2920427B2 (ja) * 1991-01-21 1999-07-19 雪印乳業株式会社 κ−カゼイングリコマクロペプチドの製造法
JP3035833B2 (ja) * 1991-01-21 2000-04-24 雪印乳業株式会社 シアル酸類含有組成物の製造方法
JP3123618B2 (ja) * 1992-03-18 2001-01-15 雪印乳業株式会社 新規ペプチド、該ペプチドを有効成分とする胃酸分泌抑制−抗潰瘍剤及び飲食品
JP3161846B2 (ja) * 1992-11-11 2001-04-25 明治乳業株式会社 牛乳ホエ−中のシアル酸結合ペプタイドの分離法
DE4344342C2 (de) * 1993-12-23 1996-08-08 Milupa Ag Molkenprotein-dominante Säuglingsnahrung
US6168823B1 (en) * 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
US5968586A (en) * 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses

Also Published As

Publication number Publication date
DE69836909T2 (de) 2007-09-06
JP4286325B2 (ja) 2009-06-24
US6787158B1 (en) 2004-09-07
CA2288184C (en) 2009-10-27
AU8107798A (en) 1998-12-30
EP0880902A1 (fr) 1998-12-02
BR9809171B1 (pt) 2011-01-11
EP0986312B1 (fr) 2007-01-17
DE69836909D1 (de) 2007-03-08
JP2002514085A (ja) 2002-05-14
EP0986312A1 (fr) 2000-03-22
AU746520B2 (en) 2002-05-02
WO1998053702A1 (fr) 1998-12-03
CA2288184A1 (en) 1998-12-03
NZ500848A (en) 2001-12-21

Similar Documents

Publication Publication Date Title
BR9809171A (pt) Processo de tratamento de uma matéria-prima láctica, contendo gmp
BR0106649A (pt) Composição fertilizante contendo enxofre e processo para preparação da mesma
DE69203958D1 (de) Produktionssystem zur Herstellung von Kleidung und anderen Produkten.
PT1133238E (pt) Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem
DE69622701D1 (de) Hemmung von tau-tau-verknüpfung
EP0431129A4 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
BR9404053A (pt) Composição para agricultura, processo para o tratamento de uma planta ou artrópode
ES2193578T3 (es) Complejos de calcio para el enriquecimiento de alimentos.
NO20064863L (no) Fremgangsmate for behandling av vannstrommer som inneholder faste biologiske stoffer
DE69103775D1 (de) Vorrichtung zur Unterscheidung von stabilen und instabilen ventriculären tachycardien.
DE69534130D1 (de) Verbindungen zur behandlung von erkrankungen,die mit des vasculogenese und/oder angiogenese in verbunden stehen.
DE69309695D1 (de) Flüssiges oder gelförmiges geschirrspülmittel, enthaltend polyhydoxyfettsäureamid, kalziumionen und alkylpolyethoxypolycarboxylat
DE69413051D1 (de) Waschmittelzusammensetzungen enthaltend mittel zur verhinderung des anlaufens von silber
BR9913156A (pt) Composição e processo para condicionamento, clareamento e realce do cabelo
BRPI0313792B8 (pt) utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
BR9407971A (pt) Produto pseudodipeptideo processo químico e enzimático de preparaçao do mesmo aplicaçao do produto e medicamento resultante da aplicaçao
DE60204584D1 (de) Zusammensetzungen enthaltend eine niedrige konzentration an peroxide zur behandlung von vaginitis
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
ES8304151A1 (es) &#34;procedimiento para eliminar total o parcialmente acido aspartico y acido glutamico de hidrolizados proteicos o mezclas de aminoacidos&#34;.
ZA903334B (en) Cleansing composition
EP0749312A4 (en) DIROFILARIA IMMITIS - Gp29 - PROTEINS, NUCLEIC ACID MOLECULES AND THEIR USE
BR9811643A (pt) Suplementação quìmica de osso
BR9900606A (pt) Processo para controlar e destruir criaturas pequenas patogênicas, particularmente inseto e vermes.
BR9005763A (pt) Utilizacao de aminoacidos protegidos contra o ph do rumen na alimentacao do carneiro

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/01/2011, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 11/00 (2006.01), A23C 9/146 (2006.0

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2516 DE 26-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.